Cargando…
Related versus unrelated allogeneic HPC graft cryopreservation: a single-center experience in the context of the global COVID-19 pandemic
Autores principales: | Mfarrej, B., Lemarié, C., Granata, A., Pagliardini, T., Malenfant, C., Lignée, P., Fays, M., Blaise, D., Chabannon, C., Calmels, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040015/ https://www.ncbi.nlm.nih.gov/pubmed/33846562 http://dx.doi.org/10.1038/s41409-020-01208-3 |
Ejemplares similares
-
Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells
por: Mfarrej, Bechara, et al.
Publicado: (2022) -
P1329: POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) VERSUS ANTITHYMOCYTE GLOBULIN (ATG) AS GVHD PROPHYLAXIS FOR MATCHED UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION.
por: Dachy, F., et al.
Publicado: (2022) -
O-09: DURABLE ENGRAFTMENT AFTER PHARMACOLOGICAL PRE-TRANSPLANT IMMUNOSUPPRESSION FOLLOWED BY REDUCED-TOXICITY MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGHLY HLA-IMMUNIZED ADULTS WITH SICKLE CELL DISEASE
por: S., FÜRST, et al.
Publicado: (2022) -
Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry
por: Fernandez-Sojo, Jesus, et al.
Publicado: (2022) -
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor
por: Devillier, Raynier, et al.
Publicado: (2021)